Meriggioli, Matthew and Roubenoff, Ronenn (2015) Prospect for Pharmacological Therapies to Treat Skeletal Muscle Dysfunction. Behavior Genetics, 45 (2). pp. 234-242. ISSN 1573-3297

Abstract

Skeletal muscle weakness is a leading cause of mobility disability in the elderly (sarcopenia), as a complication of acute or chronic illness (cachexia), and due to inherited or acquired muscle diseases (muscular dystrophies, myositides, etc.). As of now, there are no approved drugs that can reliably increase muscle strength and function. However, with our understanding of the regulation of myocyte signaling and homeostasis evolving rapidly, experimental treatments are now entering the clinic. We review the current status of clinical research in pharmacological therapies for muscle disorders.

Item Type:	Article
Keywords:	Atrophy Cachexia Muscle wasting Muscular dystrophies Sarcopenia
Date Deposited:	22 Nov 2017 00:45
Last Modified:	25 Jan 2019 00:45
URI:	https://oak.novartis.com/id/eprint/22906